Vascular and cardiac effects of DV-7028, a selective, 5-HT2-receptor antagonist in rats

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 2, 1998, Pages 266-273

  Pawlak, Dariusz ^a   Adamkiewicz, Marek ^a   Malyszko, Jolanta ^a   Takada, Akikazu ^b   Mysliwiec, Michal ^a   Buczko, Wlodzimierz ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

5HT(2A) receptor; Cardiovascular system; DV 7028

Indexed keywords

3 [2 [4 (4 FLUOROBENZOYL)PIPERIDIN 1 YL]ETHYL] 6,7,8,9 TETRAHYDRO 2H PYRIDO[1,2 A] 1,3,5 TRIAZINE 2,4(3H) DIONE; ATROPINE; KETANSERIN; RITANSERIN; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTICLE; BRADYCARDIA; CARDIOVASCULAR EFFECT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HEART RATE; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; VAGOTOMY;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CORONARY CIRCULATION; HEART; HEART RATE; HINDLIMB; INJECTIONS, INTRAVENOUS; KETANSERIN; MALE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; RITANSERIN; SEROTONIN ANTAGONISTS; TRIAZINES; VAGOTOMY;

EID: 0031856931     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199808000-00014     Document Type: Article

References (22)

1. Opper C, Weiner N, Xu F, Adam W, Fruhstorfer H, Wesemann W. Daily variations of functional parameters and density distribution in human blood platelets. Chronobiol Int 1994;11:309-19.
2. Vanhoutte PM, Lüscher TF. Serotonin and the blood vessel wall. J Hypertens 1986;(suppl 4):S29-35.
3. 2 receptor antagonist. Agents Actions 1984;43:225-34.
4. 2 receptors. Ann N Y Acad Sci 1994;717:282-92.
5. Golino P, Piscione F, Benedict CR, et al. Local effect of serotonin released during coronary angioplasty. N Engl J Med 1994;330:523-8.
6. Shibano T, Tanaka T, Morishima Y, Yasuoka M, Watanabe K, Fujii F. Pharmacological profile of a new 5-hydroxytryptamine 2 receptor antagonist, DV-7028. Arch Int Pharmacodyn Ther 1992;319:114-28.
7. Pawlak D, Malinowska B, Buczko W. Cardiovascular effects of acetaldehyde in pithed rats. Pharmacology 1992;45:83-9.
8. 2 in isolated rat hindlimb mediated through serotonin release. Eur J Pharmacol 1993;230:69-76.
9. Nicholas T. A perfused tail artery preparation from the rat. J Pharm Pharmacol 1969;21:826-32.
10. Van Rossum JM, Hurkman JA, Wolters CJJ. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodvn 1963;143:299-33.
11. 50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-108.
12. Fozard RF. Mechanism of hypotensive effect of ketanserin. J Cardiovasc Pharmacol 1982;4:829-38.
13. Hosie J, Stott DJ, Robertson JI, Ball SG. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension. J Cardiovasc Pharmacol 1987;(suppl 3)10:S86-8.
14. 2 receptors. Life Sci 1981;28:1015-22.
15. 2 receptor antagonist, on ischemic cerebral blood flow and infarct volume in rat middle cerebral artery occlusion. Stroke 1994;25:481-6.
16. Dabiré H, Cherqui C, Safar M, Shmit H. Haemodynamics aspects of serotonin. Clin Physiol Biochem 1990;8:56-63.
17. 2 receptor binding sites: binding properties, brain distribution, and functional role. Mol Pharmacol 1982;21:301-14.
18. Pott JWR, Moreland RS, Gantzos RD, Babcock C, Bohr DF. Vascular interactions of serotonin and norepinephrine in renal hypertensive rabbits. J Hypertens 1986;4:207-13.
19. Kalkman HO, Engel G, Hoyer D. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats. J Hypertens 1984;2:143-5.
20. Docherty JR. Investigations of cardiovascular 5-hydroxytryptamine receptor subtypes in the rat. Naunyn Schmiedebergs Arch Pharmacol 1988;337:1-8.
21. 2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs. J Cardiovasc Pharmacol 1994;24:761-72.
22. 2 receptor blocker, in rats. J Serotonin Res 1994;1:133-14.